Skip to main content

Calamos Advisors LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1316507 NAPERVILLE, IL

Position in LGND

as of Mar 31, 2026 · filed May 4, 2026
Position Value
$4,164,698
+$185,720 QoQ
Shares Held
20,860
-0.9% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 97.94822627037392.ToString("F0")% Shared 0.ToString("F0")% None 2.051773729626079.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Calamos Advisors LLC holds $103,200,124 across 23 Biotechnology names. LGND ranks #6 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 LGND
Ligand Pharmaceuticals Inc
This page
20,860 $4,164,698

All Filings in LGND

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,164,698 20,860
2025-12-31 $3,978,978 21,045
2025-09-30 $3,672,643 20,733
2025-06-30 $1,388,146 12,211
2025-03-31 $2,095,859 19,934
2024-12-31 $1,544,565 14,415
2024-09-30 $1,447,700 14,464
2024-06-30 $913,967 10,847
2024-03-31 $660,457 9,035
2023-12-31 $327,532 4,586
2023-06-30 $909,829 12,619
2023-03-31 $1,743,076 23,696
2022-12-31 $1,063,589 15,922